Filtry
Benefit of new "liquid biopsy" technology for monitoring of complex treatment of colorectal carcinoma in stage 3 and 4. (NV15-27939A)
The so-called “liquid biopsy” utilizing circulating-tumor DNA (ctDNA) from blood or urine as a source for molecular profiling of tumors is globally being transferred from research to clinical practice. The main benefit is the possibility for repeated...
FD - Onkologie a hematologie
- 2015 - 2019 •
- 18 737 tis. Kč •
- 16 698 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2015 - 31. 12. 2019
Uznané náklady
Podpora ze státního rozpočtu (89%)
Poskytovatel: Ministerstvo zdravotnictví
Epidemiological analysis of occurrence of congenital anomalies and tumors in children in the Czech Republic (NR9013)
Congenital anomalies (CA) have deeple influenced perinatal mortality in the Czech Republic. Lethal CA present themselves around 1/5 of perinatal mortality causes. Approximately 4 % of newborns were born with a CA in the last years. There are relation...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2006 - 2008 •
- 2 476 tis. Kč •
- 2 412 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2006 - 31. 12. 2008
Uznané náklady
Podpora ze státního rozpočtu (97%)
Poskytovatel: Ministerstvo zdravotnictví
Standardization and individualization of germ-cell tumour treatment (preparing centralization of all care to two centers in CR) (NR8442)
The centralization of the diagnostic and therapeutic programme for TGCT patients into two centres for the entire Czech Republic should enhance efficacy and reduce costs. It should also reduce mortality and increase the proportion of complete recoveri...
FD - Onkologie a hematologie
- 2005 - 2007 •
- 3 497 tis. Kč •
- 2 672 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2005 - 31. 12. 2007
Uznané náklady
Podpora ze státního rozpočtu (76%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 3 z 3